Long Cast Advisers, an investment management firm, released its fourth-quarter 2025 investor letter. A copy of the letter can ...

Cross Country Healthcare (CCRN) reported $309.94 million in revenue for the quarter ended December 2024, representing a year-over-year decline of 25.1%. EPS of $0.04 for the same period compares to $0 ...

Fintel reports that on March 5, 2026, Benchmark upgraded their outlook for Cross Country Healthcare (NasdaqGS:CCRN) from Hold to Buy. Analyst Price Forecast Suggests 27.10% Upside As of February 25, ...

Wall Street expects a year-over-year decline in earnings on lower revenues when Cross Country Healthcare (CCRN) reports results for the quarter ended December 2025. While this widely-known consensus ...

Cross Country Healthcare has seen a material decline in their share price, down 60% from the high in November 2022 following the travel nurse industry declines. There's likely still more softness ...

Cross Country Healthcare (NASDAQ:CCRN) dropped 6.2% after a report about the Federal Trade Commission's review of its planned $615 million sale to Aya Healthcare. The FTC's review of the deal has ...

Cross Country Healthcare (CCRN) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.12 per share a year ago.